On the eight and tenth of August, the chief medical officer, senior vice president of human resources, and the president of new and insured markets sold a total of 52,334 stocks.
Medco reports a 26% increase in profits for their second quarter of 2007, led by an increase in sales of generic drugs.
Medco's stock price dropped after concern about its changes to earnings-per-share estimates didn't reflect its strong first quarter.